13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001389933-25-000002
Total Value
$352.7M
Positions
83
Other Managers
1
Confidential Omitted
No
Holdings (83)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 404,505 | $32.8M | 9.30% |
| 2 | STEREOTAXIS INC | STXS | 13,680,554 | $24.1M | 6.83% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 656,176 | $23.2M | 6.58% |
| 4 | MERUS N V | N5749R100 | 461,804 | $19.4M | 5.51% |
| 5 | ATRICURE INC | ATRC | 592,273 | $19.1M | 5.42% |
| 6 | CYTOKINETICS INC | CYTK | 398,100 | $16.0M | 4.54% |
| 7 | BLUEPRINT MEDICINES CORP | 09627Y109 | 152,263 | $13.5M | 3.82% |
| 8 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $13.1M | 3.72% |
| 9 | AXOGEN INC | AXGN | 680,782 | $12.6M | 3.57% |
| 10 | ASCENDIS PHARMA A/S | ASND | 80,398 | $12.5M | 3.55% |
| 11 | IDEAYA BIOSCIENCES INC | IDYA | 589,330 | $9.7M | 2.74% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 273,739 | $9.2M | 2.60% |
| 13 | KALVISTA PHARMACEUTICALS INC | KALV | 752,359 | $8.7M | 2.46% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 71,615 | $7.9M | 2.25% |
| 15 | SYNDAX PHARMACEUTICALS INC | SNDX | 544,502 | $6.7M | 1.90% |
| 16 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 731,363 | $5.8M | 1.64% |
| 17 | TANDEM DIABETES CARE INC | TNDM | 294,208 | $5.6M | 1.60% |
| 18 | UROGEN PHARMA LTD | URGN | 492,515 | $5.4M | 1.54% |
| 19 | BIOHAVEN LTD | BHVN | 220,235 | $5.3M | 1.50% |
| 20 | MINERALYS THERAPEUTICS INC | MLYS | 309,200 | $4.9M | 1.39% |
| 21 | ARCUS BIOSCIENCES INC | RCUS | 625,126 | $4.9M | 1.39% |
| 22 | ASCENDIS PHARMA A/S | ASND | 4,000,000 | $4.7M | 1.34% |
| 23 | DEXCOM INC | DXCM | 65,552 | $4.5M | 1.27% |
| 24 | BIOCRYST PHARMACEUTICALS INC | BCRX | 558,255 | $4.2M | 1.19% |
| 25 | EDGEWISE THERAPEUTICS INC | EWTX | 183,140 | $4.0M | 1.14% |
| 26 | GALAPAGOS NV | GLPGF | 130,175 | $3.3M | 0.93% |
| 27 | INOGEN INC | INGN | 458,065 | $3.3M | 0.93% |
| 28 | INSULET CORP | PODD | 11,900 | $3.1M | 0.89% |
| 29 | ALKERMES PLC | ALKS | 94,200 | $3.1M | 0.88% |
| 30 | KURA ONCOLOGY INC | KURA | 463,368 | $3.1M | 0.87% |
| 31 | STOKE THERAPEUTICS INC | STOK | 443,998 | $3.0M | 0.84% |
| 32 | IMMUNOVANT INC | IMVT | 169,996 | $2.9M | 0.82% |
| 33 | BICARA THERAPEUTICS INC | BCAX | 212,001 | $2.8M | 0.78% |
| 34 | ACCURAY INC | ARAY | 1,222,358 | $2.2M | 0.62% |
| 35 | 2SEVENTY BIO INC | 901384107 | 429,252 | $2.1M | 0.60% |
| 36 | PROQR THERAPEUTICS N V | N71542109 | 1,567,561 | $2.1M | 0.59% |
| 37 | COMPASS PATHWAYS PLC | CMPS | 711,046 | $2.0M | 0.58% |
| 38 | ALLOGENE THERAPEUTICS INC | ALLO | 1,380,118 | $2.0M | 0.57% |
| 39 | TELA BIO INC | TELA | 1,441,029 | $1.8M | 0.50% |
| 40 | ALIGN TECHNOLOGY INC | ALGN | 11,000 | $1.7M | 0.50% |
| 41 | DENALI THERAPEUTICS INC | DNLI | 127,900 | $1.7M | 0.49% |
| 42 | ASTRIA THERAPEUTICS INC | 04635X102 | 314,775 | $1.7M | 0.48% |
| 43 | VIKING THERAPEUTICS INC | VKTX | 64,516 | $1.6M | 0.44% |
| 44 | REGULUS THERAPEUTICS INC | 75915K309 | 847,176 | $1.5M | 0.42% |
| 45 | BRAINSWAY LTD | BRSYF | 156,533 | $1.5M | 0.42% |
| 46 | ORIC PHARMACEUTICALS INC | ORIC | 242,000 | $1.4M | 0.38% |
| 47 | KEROS THERAPEUTICS INC | KROS | 130,316 | $1.3M | 0.38% |
| 48 | LEXEO THERAPEUTICS INC | LXEO | 378,083 | $1.3M | 0.37% |
| 49 | ITEOS THERAPEUTICS INC | 46565G104 | 213,347 | $1.3M | 0.36% |
| 50 | PALVELLA THERAPEUTICS INC | PVLA | 43,348 | $1.2M | 0.34% |
| 51 | ARS PHARMACEUTICALS INC | SPRY | 95,290 | $1.2M | 0.34% |
| 52 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 2,511,374 | $1.1M | 0.32% |
| 53 | ALECTOR INC | ALEC | 912,928 | $1.1M | 0.32% |
| 54 | FOGHORN THERAPEUTICS INC | FHTX | 304,752 | $1.1M | 0.32% |
| 55 | IMMATICS NV | IMTX | 245,000 | $1.1M | 0.31% |
| 56 | STRUCTURE THERAPEUTICS INC | GPCR | 59,000 | $1.0M | 0.29% |
| 57 | VYNE THERAPEUTICS INC | VYNE | 636,103 | $1.0M | 0.28% |
| 58 | MEDIWOUND LTD | MDWD | 64,479 | $1.0M | 0.28% |
| 59 | GOSSAMER BIO INC | GOSS | 907,854 | $998,639 | 0.28% |
| 60 | BIONTECH SE | BNTX | 10,500 | $956,130 | 0.27% |
| 61 | AUTOLUS THERAPEUTICS PLC | AUTL | 586,667 | $909,334 | 0.26% |
| 62 | SAGE THERAPEUTICS INC | 78667J108 | 108,200 | $860,190 | 0.24% |
| 63 | KORRO BIO INC | KRRO | 47,086 | $819,767 | 0.23% |
| 64 | CENTURY THERAPEUTICS INC | IPSC | 1,704,232 | $811,215 | 0.23% |
| 65 | LARIMAR THERAPEUTICS INC | LRMR | 371,434 | $798,583 | 0.23% |
| 66 | POLYPID LTD | PYPD | 291,273 | $789,350 | 0.22% |
| 67 | TAYSHA GENE THERAPIES INC | TSHA | 522,500 | $726,275 | 0.21% |
| 68 | BICYCLE THERAPEUTICS PLC | BCYC | 80,799 | $685,984 | 0.19% |
| 69 | NEUROGENE INC | NGNE | 51,500 | $603,065 | 0.17% |
| 70 | CARDIFF ONCOLOGY INC | CRDF | 150,000 | $471,000 | 0.13% |
| 71 | ERASCA INC | ERAS | 340,000 | $465,800 | 0.13% |
| 72 | INFLARX NV | IFRX | 450,000 | $459,000 | 0.13% |
| 73 | ADICET BIO INC | ACET | 600,000 | $453,000 | 0.13% |
| 74 | AQUESTIVE THERAPEUTICS INC | AQST | 142,000 | $411,800 | 0.12% |
| 75 | COMPUGEN LTD | CGEN | 272,402 | $397,707 | 0.11% |
| 76 | ADC THERAPEUTICS SA | ADCT | 224,081 | $315,954 | 0.09% |
| 77 | SUTRO BIOPHARMA INC | STRO | 437,079 | $284,364 | 0.08% |
| 78 | APREA THERAPEUTICS INC | APRE | 137,174 | $279,835 | 0.08% |
| 79 | BIOMX INC | PHGE | 401,136 | $222,911 | 0.06% |
| 80 | NEVRO CORP | 64157F103 | 38,000 | $221,920 | 0.06% |
| 81 | BLACK DIAMOND THERAPEUTICS I | BDTX | 140,000 | $217,000 | 0.06% |
| 82 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $90,000 | 0.03% |
| 83 | TENAYA THERAPEUTICS INC | TNYA | 47,319 | $26,977 | 0.01% |